SCHEMBL9997227

SCHEMBL9997227

CCC/C=C(\CC)C(OC(C)=O)OC(C)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.39
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
GALR3 O60755 1/20 0.34
MAPT P10636 1/20 0.34
BLM P54132 1/20 0.34
GRIK1 P39086 1/20 0.33
GRIK2 Q13002 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP3A4 P08684 5/20 0.33
CYP2C9 P11712 4/20 0.33
CYP2C19 P33261 4/20 0.33
CYP2D6 P10635 1/20 0.33
CYP1A2 P05177 3/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPK1 P28482 1/20 0.30
TRPV1 Q8NER1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997228 1.00 TSHR (0.39) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL9998215 0.89 TSHR (0.37) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL9998217 0.89 TSHR (0.37) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL9997337 0.87 EP300 (0.43) TSHRMAPTALDH1A1LMNA
SCHEMBL9997336 0.87 EP300 (0.43) TSHRMAPTALDH1A1LMNA
SCHEMBL9997143 0.86 CYP3A4 (0.40) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL9997141 0.86 CYP3A4 (0.40) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL9998622 0.85 EP300 (0.46) MAPTBLMALOX15CYP2C9CYP2C19
SCHEMBL9998625 0.85 EP300 (0.46) MAPTBLMALOX15CYP2C9CYP2C19
SCHEMBL9997901 0.85 EP300 (0.46) MAPTBLMALOX15CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 TSHR 621/4885CHRM2 1299/4885CHRM4 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.